Pallas Capital Advisors LLC Biomarin Pharmaceutical Inc Transaction History
Pallas Capital Advisors LLC
- $2.21 Billion
- Q4 2024
A detailed history of Pallas Capital Advisors LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 3,206 shares of BMRN stock, worth $200,471. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,206
Previous 7,144
55.12%
Holding current value
$200,471
Previous $502,000
58.17%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
639Shares Held
178MCall Options Held
2MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.42 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.21 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.18 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$869 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$656 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...